Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015152 |
---|---|
Receipt number | R000017623 |
Scientific Title | Phase II study of first-line treatment by FOLFOXIRI+bevacizumab in patients with RAS mutant-type metastatic colorectal cancer |
Date of disclosure of the study information | 2014/10/01 |
Last modified on | 2019/03/08 10:10:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/09/14 15:03:09 | ||
2 | Update | 2016/11/15 13:37:22 | Interventions/Control_1 Key inclusion criteria |
|
3 | Update | 2016/11/15 13:39:39 | Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization |
|
4 | Update | 2016/11/15 13:41:04 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
5 | Update | 2018/03/08 08:48:22 | Publication of results |
|
6 | Update | 2019/03/08 10:10:52 | Recruitment status |